Bender, O. Et Al. 2023. Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation. ARCHIV DER PHARMAZIE , vol.356, no.2 .

Bender, O., Shoman, M., Ali, T. F. S., Dogan, R., Celik, I., Mollica, A., ... Hamed, M. I. A.(2023). Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation. ARCHIV DER PHARMAZIE , vol.356, no.2.

Bender, Onur Et Al. "Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation," ARCHIV DER PHARMAZIE , vol.356, no.2, 2023

Bender, Onur Et Al. "Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation." ARCHIV DER PHARMAZIE , vol.356, no.2, 2023

Bender, O. Et Al. (2023) . "Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation." ARCHIV DER PHARMAZIE , vol.356, no.2.

@article{article, author={Onur Bender Et Al. }, title={Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation}, journal={ARCHIV DER PHARMAZIE}, year=2023}